BioArctic Partners With Eli Lilly Over Potential New Treatment To Combine BrainTransporter Technology with Lilly's Undisclosed Drug Candidate In Neurodegeneration; BioArctic Eligible To Receive $30M Upfront Payment

Benzinga Newsdesk www.benzinga.com Neutral 84.6%

Neg 0% Neu 84.6% Pos 0%

https://mfn.se/cis/a/bioarctic/bioarctic-and-lilly-sign-research-and-collaboration-agreement-combining-lilly-compound-with-bioarctics-braintransporter-technology-586e7661c